Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity
2022 | journal article. A publication with affiliation to the University of Göttingen.
Erratum to this publicationJump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Design of New Potent and Selective Thiophene-Based KV1.3 Inhibitors and Their Potential for Anticancer Activity
Gubič, Š.; Hendrickx, L. A.; Shi, X.; Toplak, Ž.; Možina, Š.; Theemsche, K. M. V. & Pinheiro-Junior, E. L. et al. (2022)
Cancers, 14(11) pp. 2595. DOI: https://doi.org/10.3390/cancers14112595
Documents & Media
Details
- Authors
- Gubič, Špela; Hendrickx, Louise Antonia; Shi, Xiaoyi; Toplak, Žan; Možina, Štefan; Theemsche, Kenny M. Van; Pinheiro-Junior, Ernesto Lopes; Peigneur, Steve; Labro, Alain J.; Pardo, Luis A.; Mašič, Lucija Peterlin
- Abstract
- The voltage-gated potassium channel KV1.3 has been recognized as a tumor marker and represents a promising new target for the discovery of new anticancer drugs. We designed a novel structural class of KV1.3 inhibitors through structural optimization of benzamide-based hit compounds and structure-activity relationship studies. The potency and selectivity of the new KV1.3 inhibitors were investigated using whole-cell patch- and voltage-clamp experiments. 2D and 3D cell models were used to determine antiproliferative activity. Structural optimization resulted in the most potent and selective KV1.3 inhibitor 44 in the series with an IC50 value of 470 nM in oocytes and 950 nM in Ltk− cells. KV1.3 inhibitor 4 induced significant apoptosis in Colo-357 spheroids, while 14, 37, 43, and 44 significantly inhibited Panc-1 proliferation.
- Issue Date
- 2022
- Journal
- Cancers
- eISSN
- 2072-6694
- Language
- English